In appropriately selected men and women, statin therapy appears to be associated with significant decreases in cardiovascular events regardless of gender, according to a large meta-analysis. When compared with control groups, both genders experienced statistically significant benefits in primary and secondary prevention endpoints with statins.
Abstract: Journal of the American College of Cardiology, February 2012.
